Pharmaceutical Manufacturer Kickback Resolutions and Associated Financial Penalties, 2000-2025
This cross-sectional study investigates the size of financial penalties levied by the US government against pharmaceutical companies accused of violating the Anti-Kickback Statute.
Authors
- Christopher J. Morten
- Tobias Liu
- Reshma Ramachandran
- Joseph S. Ross
Institutions
- New York Law School (US)
- Yale University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.1735
- Primary Topic
- Auditing, Earnings Management, Governance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Greenwall Foundation
- Arnold Ventures